Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis

OBJECTIVE: Non-alcoholic fatty liver disease is highly prevalent in patients with type 2 diabetes mellitus. Studies on glucagon-like peptide-1 receptor agonists for the treatment of non-alcoholic fatty liver disease have reported promising results. Despite this, there has been limited evidence of it...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Endocrinol (Lausanne)
Autori principali: Wong, Chloe, Lee, Ming Hui, Yaow, Clyve Yu Leon, Chin, Yip Han, Goh, Xin Lei, Ng, Cheng Han, Lim, Amanda Yuan Ling, Muthiah, Mark Dhinesh, Khoo, Chin Meng
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Endocrinology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8063104/
https://ncbi.nlm.nih.gov/pubmed/33897616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.609110
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi